The accreditors of this session require that you periodically check in to verify that you are still attentive. Please click the button below to indicate that you are.
An ISHLT 2020 Oral Session Presentation
Scientific Program Agenda:
Moderator:
Sarah Medrek, MD, University of New Mexico, Albuquerque, NM, USA
Welcome, Session Overview
Oksana Shlobin, MD, Inova Fairfax Hospital, Falls Church, VA, USA
Liaison, ISHLT 2020 Program Committee PH Group
Program Introduction
Moderator
A. Vonk Noordegraaf1, R. Channick2, E. Cottreel3, D. Kiely4, N. Martin3, O. Moiseeva5, A. Peacock6, A. Tawakol7, A. Torbicki8, S. Rosenkranz*9, N. Galiè* (*co-last authors)10. 1Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands, 2David Geffen School of Medicine at UCLA, Los Angeles, CA, 3Actelion Pharmaceuticals Ltd, Allschwil, Switzerland, 4Royal Hallamshire Hospital, Sheffield, United Kingdom, 5Almazov National Medical Research Centre, St Petersburg, Russian Federation, 6Scottish Pulmonary Vascular Unit, Glasgow, United Kingdom, 7Massachusetts General Hospital and Harvard Medical School, Boston, MA, 8Department of Pulmonary Circulation CMKP at European Health Center, Otwock, Poland, 9Heart Center at the University of Cologne, and Cologne Cardiovascular Research Center (CCRC), Cologne, Germany, 10Department of Experimental, Diagnostic and Specialty Medicine – DIMES, University of Bologna, Bologna, Italy
N. S. Hill1, J. P. Feldman2, S. Sahay3, D. Levine4, R. F. Roscigno5, T. A. Vaughn5, T. M. Bull6. 1Pulmonary, Tufts Medical Center, Boston, MA, 2Arizona Pulmonary Specialists, Phoenix, AZ, 3Houston Methodist Hospital, Houston, TX, 4University of Texas Health Sciences Center at San Antonio, San Antonio, TX, 5Liquidia Technologies, Morrisville, NC, 6Anschutz Medical Campus, University of Colorado Denver, Aurora, CO
R. F. Bentley1, M. Barker1, S. Esfandiari1, S. P. Wright1, F. H. Valle1, J. T. Granton2, S. Mak1. 1Division of Cardiology, Sinai Health System, Toronto, ON, Canada, 2Division of Respirology, University Health Network, Toronto, ON, Canada
R. L. Benza1, H. W. Farber2, A. E. Frost3, H. A. Ghofrani4, P. A. Corris5, B. Brockmann6, S. Nikkho7, C. Meier8, M. M. Hoeper9. 1Ohio State University, Columbus, OH, 2Pulmonary Hypertension Center, Boston University/Boston Medical Center, Boston, MA, 3Department of Medicine, Houston Methodist, Houston, TX, 4Member of the German Center for Lung Research (DZL), University of Giessen and Marburg Lung Center (UGMLC), Glessen, Germany, 5Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 6CHRESTOS Concept GmbH & Co. KG, Essen, Germany, 7Global Clinical Development, Bayer AG, Berlin, Germany, 8Global Medical Affairs, Bayer AG, Berlin, Germany, 9Clinic for Respiratory Medicine, Hannover Medical School, member of the German Center for Lung Research (DZL), Hannover, Germany
E. Vasti1, A. Papolos2, N. A. Kolaitis3, J. Mayfield3, G. H. Tison2, T. De Marco4. 1Department of Medicine, University of California, San Francisco, San Francisco, CA, 2Department of Medicine, Division of Cardiology, University of California, San Francisco, San Francisco, CA, 3Department of Medicine, Division of Pulmonology, University of California, San Francisco, San Francisco, CA, 4Department of Medicine, Division of Cardiology, University of California, San Francisco, University of California, CA
(18) Right Atrial Pacing to Improve Acute Hemodynamics in Pulmonary Arterial Hypertension
J. S. Khural1, B. A. Houston1, P. J. Leary2, S. C. Mathai3, T. M. Kolb3, R. Damico3, H. M. Paul3, D. A. Kass4, S. Hsu4, R. J. Tedford1. 1Division of Cardiology, Department of Medicine, The Medical University of South Carolina, Charleston, SC, 2Division of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Washington, Seattle, WA, 3Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, 4Division of Cardiology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD
Q & A Segment with all presenters
Led by Moderator
ISHLT Pulmonary Vascular Disease Interdisciplinary Network Update
Ioana Preston, MD, Tufts Medical Center, Boston, MA, USA
Chair, Pulmonary Vascular Disease Interdisciplinary Network Steering Committee
ISHLT Announcements
Greg Schultz, CEO, ISHLT, Addison, TX, USA
Adjourn
You must be logged in and own this session in order to post comments.
Item | Price | Remove |
---|